Leveraging the Best Practice When Designing and Running a CAR-T Clinical Trial in Autoimmune and Oncology Indications
Time: 11:45 am
day: Conference Day One - Track B
Details:
- Operational and regulatory environment considerations surrounding CAR T trials in autoimmune and oncology – regulatory, patient care and site perspectives; current treatment landscape
- Practicalities of running a CAR T trial in U.S vs globally.
- Best approaches and strategies to build internal clinical operations team and CRO partnerships
